Karie Runcie, MD, discusses the mechanism of action of XmAb30819 in clear cell RCC.
Karie Danielle Keera Runcie, MD
Advertisement
Karie Danielle Keera Runcie, MD, is the assistant professor of medicine at Columbia University Irving Medical Center and a medical oncologist at NewYork-Presbyterian/Columbia.
Articles by Karie Danielle Keera Runcie, MD
Karie Danielle Keera Runcie, MD, discusses treatment challenges after progression on adjuvant therapy and the potential role for zanzalintinib in renal cell carcinoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5